Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progressionWeibo Luo, Gregg L. Semenza|Proceedings of the National Academy of Sciences|2012Cited by 228
ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasisYan Chen, Weibo Luo|Journal of Clinical Investigation|2018Cited by 181
p24A, a Type I Transmembrane Protein, Controls ARF1-dependent Resensitization of Protease-activated Receptor-2 by Influence on Receptor TraffickingWeibo Luo, Georg Reiser|Journal of Biological Chemistry|2007Cited by 63
Targeting BCAT1 Combined with α-Ketoglutarate Triggers Metabolic Synthetic Lethality in GlioblastomaBo Zhang, Weibo Luo|Cancer Research|2022Cited by 56
ZMYND8 protects breast cancer stem cells against oxidative stress and ferroptosis through activation of NRF2Maowu Luo, Weibo Luo|Journal of Clinical Investigation|2024Cited by 51